AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $488,398 | +106.2% | 14,177 | 0.0% | 0.01% | +125.0% |
| Q2 2020 | $236,898 | +15.9% | 14,177 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $204,432 | -57.5% | 14,177 | -1.3% | 0.00% | -50.0% |
| Q4 2019 | $480,930 | +59.8% | 14,369 | 0.0% | 0.01% | +60.0% |
| Q3 2019 | $300,887 | +0.6% | 14,369 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $299,163 | -6.8% | 14,369 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $321,147 | -6.6% | 14,369 | 0.0% | 0.01% | -14.3% |
| Q4 2018 | $343,706 | -12.3% | 14,369 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $391,986 | -99.9% | 14,369 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $386,383,000 | +2.3% | 14,369 | +21.1% | 0.01% | +20.0% |
| Q1 2018 | $377,758,000 | +85754.1% | 11,868 | +2.1% | 0.01% | -16.7% |
| Q4 2017 | $440,000 | -28.3% | 11,627 | -53.1% | 0.01% | +50.0% |
| Q3 2017 | $614,000 | +20.6% | 24,773 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $509,000 | +20.6% | 24,773 | +27.7% | 0.00% | +33.3% |
| Q1 2017 | $422,000 | -0.7% | 19,401 | -6.7% | 0.00% | 0.0% |
| Q4 2016 | $425,000 | +36.2% | 20,796 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $312,000 | +38.7% | 20,796 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $225,000 | +73.1% | 20,796 | +116.2% | 0.00% | +100.0% |
| Q1 2016 | $130,000 | -20.2% | 9,617 | +9.0% | 0.00% | 0.0% |
| Q4 2015 | $163,000 | – | 8,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|